Bakshi Finance — Family Office
The information presented on this site is provided for informational and educational purposes only. It does not constitute investment advice, investment marketing, or a substitute for personalised advice. The firm operates as a Family Office serving qualified investors. The firm’s founder held a licensed investment-advisory practice from 2008 through 2023. This site does not participate in the investment decision.

Elbit Systems Ltd.

Elbit Systems Ltd. | NASDAQ + TASE | Defense — Defense Electronics

Data current as of: March 2026 | Primary source: SEC 20-F FY2025

ESLT
Research Depth · Standard Defense · Israeli Mega-cap
Revenue 2025
$7.94B
+16.3% Y/Y | 5-year high
Diluted EPS 2025
$11.39
2023: $4.82 (+141%)
Net Income 2025
$534M
2024: $321M (+66%)
Operating Margin 2025
8.5%
2023: 6.2% (+2.3pp)
FCF 2025
$553M
2023: ($73M) — inflection
R&D 2025
$517M
6.5% of revenue
Market Cap
$37.5B
NASDAQ + TASE | Apr 2026
P/E Ratio
68.7
TTM | Forward P/E: 56.6
EV/EBITDA
43.8
EBITDA: $859M (TTM)
Net Debt
$149M
Debt $965M − Cash+ST $816M
Gross Margin
24.4%
2025 | Gross Profit $1.94B
1 Company Profile

Elbit Systems is Israel’s largest defence company, founded in 1966, traded on NASDAQ and on the Tel Aviv Stock Exchange, and a constituent of the TA-35 index. Headquartered in Haifa, it operates in more than 50 countries with subsidiaries in the US (Elbit Systems of America), the UK, Germany and others. Elbit is regarded as the flagship of Israel’s publicly traded defence industry — a large private-sector defence company by global standards (as opposed to state-owned Rafael and IAI), while at the same time listed on NASDAQ with global capital-market accessibility. The portfolio spans land, air and naval systems, C4ISR, cyber, and training services.

SegmentDescription
AerospaceAircraft, UAVs, precision munitions, simulators
C4I and CyberCommunications, cyber, autonomous solutions
ISTAR and EWElectro-optics, electronic warfare, naval systems
LandArmored vehicles, artillery, ammunition, defense systems
ESA (USA)US operations — Elbit Systems of America

Source: Form 20-F FY2025

2 Key Financial Observations

This summary is not a recommendation. It is a factual list of key financial metrics.

Performance — 5 Years ($M)

YearRevenueNet ProfitOperating Margin
20215,2792747.9%
20225,5122756.7%
20235,9752156.2%
20246,8283217.2%
20257,9395348.5%

Operating Expenses 2025 ($M)

Expense20252024% Revenue
R&D5174666.5%
Sales & Marketing3993755.0%
General & Administrative3473114.4%
FCF (total)553
Debt Repayment496
Dividends124100

Missing data: Full geographic backlog breakdown, precise net debt, standalone EBITDA, revenue split by segment and year.

Revenue — 5 Years ($M)
Net Profit — 5 Years ($M)
Operating Margin — Trend (%)
Diluted EPS — 5 Years ($)
R&D + Sales + G&A ($M)
Revenue Growth YoY (%)
3 Industry & Competitive Context

Defense and defense electronics — a non-cyclical market, stable government defense budgets, long-term contracts. Concentrated market structure — dominated by a small number of approved players in each country. Global rise in defense budgets driven by Ukraine, tensions in Taiwan, and the Israel war.

CompetitorDomainKey Distinction
RafaelWeapon and defense systems (Iron Dome)Israeli state-owned company — partner and competitor
IAIUAVs, space, naval systemsIsraeli state-owned company
L3HarrisDefense electronicsMajor US competitor
Northrop GrummanDefense and intelligence systemsBroad access to Pentagon budget
BAE SystemsArmored vehicles, electronicsUK competitor
ThalesC4I, electro-opticsFrench competitor
4 Risk Factors
RiskContext
Defense budget dependencyMost revenue comes from governments. A change in defense policy of a major country (Israel, USA, NATO) will affect directly
Israeli customer concentrationThe State of Israel is a dominant customer. A budgetary crisis would have a major impact
Geopolitical riskExport restrictions or sanctions can block markets. High sensitivity to international sentiment toward Israel
Low tax rate 2025 (9.9%)If it is a one-off, 2026 net income will show normalization downward even if operations remain the same
Ownership concentration (Federmann 41.6%)Family structure raises corporate governance questions
Two-way operating leverageThe same leverage that doubled profit will operate in reverse if revenues slow — operating margins may fall back to 6-7%
US competitionL3Harris, Northrop Grumman with vast resources and access to DOD budget
5 Analytical Lens — The Questions We Ask
In professional company analysis, the question is not "is this good?" but rather "through which lenses must this company be examined so that we do not miss what matters most?" At Bakshi Finance, every analysis passes through six lenses. The text below is not an assessment — it is the mapping of the questions this analysis is meant to answer.

This framework is intended to structure analysis, not to produce an investment conclusion.
Growth
Revenue accelerated from CAGR ~5% (2021-2023) to +14-16% (2024-2025). How much of the growth is healthy organic (new contracts) versus a reaction to the Israel-conflict (one-shot)? How does the 3-5 year backlog look? What is the geographic distribution of new contracts?
Profitability
Operating margins jumped from 6.2% to 8.5% in two years. How much is operating leverage on a fixed cost base (temporary) and how much is structural (product mix, efficiency)? What is the reasonable ceiling?
Leverage
Debt repayment of $496M in 2025 — aggressive. What is the remaining debt and Debt/EBITDA ratio? How is the debt structure exposed to rate increases? Can the company continue investing in R&D while reducing debt simultaneously?
Competitive Position
Elbit is a globally leading defence company in certain domains (UAVs, electro-optics). What is the actual technological differentiation versus IAI and Rafael domestically? How does it compete against L3Harris/Northrop in global deals?
Management Quality
2024-2025 execution has been impressive. How much of the results reflect management versus macro tailwinds? How does the Federmann family (41.6%) influence decisions? Is there succession-planning risk?
Business Complexity / Risk
Elbit operates in five segments, 50+ countries, varied export regulations. How to treat Israeli exposure on one hand, and growing US activity (ESA) on the other? What is the USD/ILS sensitivity?
6 Scenario Framework
Scenarios are descriptive, not predictive. They outline possible conditions, not expected outcomes.
These scenarios carry no probability assessment, no preferred direction, and no expectation regarding which, if any, will materialise.
Constructive Scenario — if the following conditions hold:

Global defence budgets continue to rise (US, NATO, Asia), backlog continues to grow, additional European countries purchase Elbit systems (precision munitions, UAVs), the normalising tax rate is sustained in a favourable way, and operating margins stabilise around 9-10%. Under these conditions, EPS continues to grow double-digit and the dividend rises.

Base Scenario — if current trends continue:

Israeli defence spending stabilises at a high level (no longer rising), global growth at 7-10% annually, operating margins remain around 8-9%, tax rate reverts to a normal 15-18%. Net income grows at a high single-digit pace.

Adverse Scenario — if the following risks materialise:

A Middle East settlement rapidly reduces Israeli demand, diplomatic pressure on European countries cuts procurement from Israel, the tax rate normalises (15-18%) and compresses profit, or negative operating leverage compresses margins. Under these conditions, EPS may fall back toward $7-8.

Scenarios describe conditions, not forecasts. There is no preferred direction and no probability assessment expressed in this framework.
7 How to Think About This Company
Elbit is not a typical defence company — over the past two years it has transformed from a modest-growth story into a profit-doubling story. EPS rose 141% between 2023 and 2025, operating profit doubled, operating margins improved by 2.3 percentage points. This is unusual in a defensive industry under normal circumstances. This transformation is the source of both the upside and the risk — upside, because the company demonstrated exceptional execution under pressure; risk, because part of the improvement may be a one-off reflection of the Israel-conflict rather than structural. The real question in analysing Elbit is not "is the growth real" (it is), but rather "how much of it will sustain once the Israeli security situation stabilises?"
The critical variables to monitor are three. First, backlog composition. 2025 revenue reflects execution of contracts signed in 2022-2024. 2026-2027 growth depends on contracts signed now. If backlog continues to grow and is geographically diversified (not only Israel), growth will persist. Second, the tax rate. 9.9% in 2025 is exceptional; a normal rate is 15-18%. If 2026 sees tax reverting, net income faces 6-9% pressure even if operations hold steady. The market may read this as real deceleration. Third, operating margins. The improvement from 6.2% to 8.5% is mostly operating leverage. The question is whether it stabilises, continues, or reverses if growth slows.
Where the analysis may go wrong. First error — treating the 14-16% growth rate as run-rate. This is an exceptional pace for a defence company, and in Elbit’s history (CAGR 2021-2023 = ~5%) it is not the standard. More likely, long-term growth is 7-10%. Second error — treating $534M net income as clean. A 9.9% tax rate added ~$40-50M above normal; some operating profit is the result of a cost base that has not caught up with the new sales pace. Third error — treating Elbit as a "US defence equity" (like Lockheed or RTX). It shares business characteristics, but it is an Israeli company with unique exposure to the local security situation, different export regulations, and international sentiment.
What distinguishes professional analysis of Elbit from headlines. Headlines on Elbit speak of "record profit" or "the war pushed the stock". Professional analysis addresses three things: (a) the ratio of organic-structural growth to war-driven growth — and how long it will take to clarify; (b) net-income sensitivity to a normal tax rate — every 5% rise in tax rate is worth ~$30M less profit; (c) the scenario of reversion to normal — whether the company grew its recurring revenue base enough to avoid falling back to 2023 levels, or whether it is a temporary lift. These are not what one buys or sells — they are what one asks before deciding.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
8 Sources & Data
#SourceDateType
1SEC EDGAR — Form 20-F FY2025March 2026Official — SEC
2SEC EDGAR — Form 20-F FY2023March 2024Official — SEC
3elbitsystems.com — IRQuarterlyOfficial — company website
4maya.tase.co.il — Company details (Elbit)April 2026Official — Stock Exchange
5NASDAQ.com — ESLT quoteApril 2026Official — Stock Exchange
6stockanalysis.com — MultiplesApril 2026Secondary

Missing: Backlog geographic breakdown, precise net debt, standalone EBITDA, revenue split by segment and year.

🔒

Premium Content — Qualified Investors Only

The full Elbit Systems (ESLT) analysis is available to Premium members of Bakshi Finance — Family Office.
The analysis includes a professional review across 8 structured sections, 6 charts and a framework of scenarios.

Unlock Analysis — $60 $60 per analysis · $900 / year for full access
10

Analytical Lens — The Questions We Ask

In professional company analysis, the question is not "is this good?" but rather "through which lenses must this company be examined so that we do not miss what matters most?" Every analysis at Bakshi Finance passes through six lenses. The text below is not an assessment — it is the mapping of the questions this analysis is meant to answer.

The analysis is based on an internal multi-factor analytical framework used in professional portfolio management. The framework maps the questions; the answers appear woven through the analysis above.

What this lens is not: there is no rating, no score, no comparison between this company and any other, and no preference. The same six questions are asked of every company on the site — the variation is in the answers, not in the instrument.

This framework is intended to structure analysis, not to produce an investment conclusion.

📈
Growth
How does the company grow? Does growth come from volume, price, or mix? Is it stable across cycles?
💰
Profitability
How do profit margins behave over time? How much of accounting earnings actually converts into free cash flow?
⚖️
Leverage
What is the capital structure? With what flexibility can the company handle a downturn or high financing costs?
🏰
Competitive Position
What protects its revenues from erosion? How long is that protection expected to hold?
👔
Management Quality
How does management allocate capital? What is its track record on strategic decisions?
🧩
Business Complexity / Risk
Where would a simplistic analysis go wrong? What is exposed to regulation, cyclicality, or technological change?

Key Observations

This summary is not a recommendation. It is a factual list of what the analysis has identified. The decision rests with the client.

Disclosure — Family Office

Bakshi Finance operates as a Family Office serving qualified investors only. Mr. Yaron Bakshi held a licensed investment-advisory practice from 2008 through 2023. As of the publication date of this document, the firm does not hold a license for investment advice, investment marketing, or portfolio management. This document is intended for research and professional educational purposes only. Nothing herein constitutes a recommendation to buy, sell, hold, or take any action in securities. Nothing herein substitutes for advice that takes into account the data and needs of each individual. Every decision — rests solely with the investor. Past performance is not indicative of future results.